Schedule 13G ownership disclosure

NeuroBo Pharmaceuticals, Inc.

Security class unavailable · CUSIP: 64132R206

Event date: 2023-03-20

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1
Percent of class
6.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001971160-23-000005
Form type
SC 13G
Filer
MetaVia Inc.
CIK
CIK 1638287
Filed
Mar 28, 2023
Reporting period
Mar 20, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub